FABP2 Ala54Thr genotype is associated with glucoregulatory function and lipid oxidation after a high-fat meal in sedentary nondiabetic men and women

American Journal of Clinical Nutrition

Volumn 85, Issue 1, 2007, Pages 102-108

  Weiss, Edward P ^a,d   Brandauer, Josef ^a   Kulaputana, Onanong ^a   Ghiu, Ioana A ^a   Wohn, Christopher R ^a   Phares, Dana A ^a   Shuldiner, Alan R ^b,c   Hagberg, James M ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Fatty acid binding protein; Genotype; Glucose tolerance; Insulin action; Lipid oxidation; Postprandial lipemia

Indexed keywords

ALANINE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 2; GLUCOSE; THREONINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HYPERLIPIDEMIA; INSULIN SENSITIVITY; LIPID DIET; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; SITTING;

EID: 33846051501     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.1.102     Document Type: Article

References (34)

1. Silver KD, Shuldiner AR. Candidate genes for type 2 diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes mellitus: a fundamental and clinical text. Philadelphia, PA: Lippincott Williams & Wilkins, 2000:705-19.
2. Weiss EP, Brown MD, Shuldiner AR, Hagberg JM. Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects. Physiol Genomics 2002;10:145-57.
3. Zhang F, Lucke C, Baier LJ, Sacchettini JC, Hamilton JA. Solution structure of human intestinal fatty acid binding protein with a naturally-occurring single amino acid substitution (A54T) that is associated with altered lipid metabolism. Biochemistry 2003;42:7339-47.
4. Baier LJ, Sacchettini JC, Knowler WC, et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995;95:1281-7.
5. Baier LJ, Bogardus C, Sacchettini JC. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 1996;271:10892-6.
6. Levy E, Menard D, Delvin E, et al. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem 2001;276:39679-84.
7. Georgopoulos A, Aras O, Tsai MY. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab 2000;85:3155-60.
8. Agren JJ, Vidgren HM, Valve RS, Laakso M, Uusitupa MI. Postprandial responses of fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am J Clin Nutr 2001;73:31-5.
9. Agren JJ, Valve R, Vidgren H, Laakso M, Uusitupa M. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 1998;18:1606-10.
10. Pratley RE, Baier L, Pan DA, et al. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 2000;41:2002-8.
11. Tahvanainen E, Molin M, Vainio S, et al. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis 2000;152:317-25.
12. Kim CH, Yun SK, Byun DW, Yoo MH, Lee KU, Suh KI. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean men. Metabolism 2001;50:473-6.
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(suppl 1):S43-8.
14. Wilund KR, Ferrell RE, Phares DA, Goldberg AP, Hagberg JM. Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype. Metabolism 2002;51:774-8.
15. Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102:2284-99.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988;16:1215.
17. Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer FX. The use of areas under curves in diabetes research. Diabetes Care 1995;18:245-50.
18. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70.
19. Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM Jr. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A 1983;80:1449-53.
20. Shuter B, Aslani A. Body surface area: Du Bois and Du Bois revisited. Eur J Appl Physiol 2000;82:250-4.
21. Katzel LI, Busby-Whitehead MJ, Rogus EM, Krauss RM, Goldberg AP. Reduced adipose tissue lipoprotein lipase responses, postprandial lipemia, and low high-density lipoprotein-2 subspecies levels in older athletes with silent myocardial ischemia. Metabolism 1994;43:190-8.
22. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 1988;37:287-301.
23. Dengel DR, Hagberg JM, Coon PJ, Drinkwater DT, Goldberg AP. Effects of weight loss by diet alone or combined with aerobic exercise on body composition in older obese men. Metabolism 1994;43:867-71.
24. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990;51:1106-12.
25. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. Baltimore, MD: Williams & Wilkins, 1995.
26. Brown MD, Shuldiner AR, Ferrell RE, et al. FABP2 genotype is associated with insulin sensitivity in older women. Metabolism 2001;50:1102-5.
27. Marin C, Perez-Jimenez F, Gomez P, et al. The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am J Clin Nutr 2005;82:196-200.
28. Lefevre M, Lovejoy JC, Smith SR, et al. Comparison of the acute response to meals enriched with cis- or trans-fatty acids on glucose and lipids in overweight s with differing FABP2 genotypes. Metabolism 2005;54:1652-8.
29. Schrauwen P, Wagenmakers AJ, Marken Lichtenbelt WD, Saris WH, Westerterp KR. Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation. Diabetes 2000;49:640-6.
30. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998;14:263-83.
31. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002;51:7-18.
32. Ivy JL, Zderic TW, Fogt DL. Prevention and treatment of non-insulin-dependent diabetes mellitus. Exerc Sport Sci Rev 1999;27:1-35.
33. Bergman RN, Mittelman SD. Central role of the adipocyte in insulin resistance. J Basic Clin Physiol Pharmacol 1998;9:205-21.
34. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006;116:1802-12.